Darmstadt, Germany

Martin Hils

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Damstadt, DE (2014)
  • Darmstadt, DE (2016 - 2022)

Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Martin Hils: Pioneering Advances in Blood Coagulation Research

Introduction: Martin Hils is an innovative inventor based in Darmstadt, Germany, known for his contributions to the field of blood coagulation research. With a total of four patents to his name, Hils has made significant strides in developing novel compounds that aim to improve therapeutic outcomes for patients affected by various blood coagulation disorders.

Latest Patents: Among his most recent inventions, Hils holds patents for inhibitors of blood coagulation factor XIII and inhibitors of transglutaminases. The first patent focuses on a compound of general formula (I), which serves as a novel inhibitor of blood coagulation factor XIII. This compound has potential applications in the prophylaxis and treatment of diseases associated with this coagulation factor. The second patent similarly describes a compound of general formula (I) designed as a novel inhibitor of transglutaminases, along with methods for producing these compounds and pharmaceutical compositions that contain them for treating diseases linked to transglutaminases.

Career Highlights: Hils is currently employed at Zedira GmbH, where his work primarily revolves around the development of innovative solutions in pharmaceutical chemistry. His expertise in coagulation pathways and enzyme inhibition has positioned him as a valuable asset in the scientific community.

Collaborations: Throughout his career, Martin Hils has collaborated with esteemed professionals such as Ralf Pasternack and Christian Büchold. Their teamwork has fostered a productive research environment that encourages the development of cutting-edge biomedical solutions.

Conclusion: Martin Hils exemplifies the spirit of innovation and dedication typical of leading inventors in the scientific field. Through his patents and collaborations, he is significantly contributing to our understanding and treatment of blood coagulation disorders. His ongoing work at Zedira GmbH continues to hold promise for future advancements in this vital area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…